Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The
2 agonist debate in the early 1990s
overshadowed the introduction of salmeterol, resulting in greater
emphasis on higher doses of inhaled steroids for control of asthma. On
p 1368 Shrewsbury et al report on a meta-analysis of the benefit of
adding salmeterol compared with increasing the dose of steroids. The
addition of long acting bronchodilator resulted in greater benefit for
lung function, better control of symptoms, and reduced use of rescue medication compared with an increased dose of steroids. Additionally, fewer patients experienced exacerbations.